Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-04-24 8:59 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Nisco James See Remarks | 0 | $0 | 21,398 (Direct) | View |
| 2024-01-11 Tax Withholding | 2024-01-12 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 1,026 | $2.99 | 174,766 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:11 pm | 2024-01-09 2034-01-09 | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 41,000 | $0 | 68,035 (Direct) | View |
| 2024-01-09 Tax Withholding | 2024-01-11 4:11 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 5,368 | $3.08 | 68,035 (Direct) | View |
| 2024-01-10 Tax Withholding | 2024-01-11 4:11 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 512 | $3 | 68,035 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:10 pm | 2024-01-09 2034-01-09 | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 141,000 | $0 | 222,792 (Direct) | View |
| 2024-01-09 Tax Withholding | 2024-01-11 4:10 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 20,046 | $3.08 | 222,792 (Direct) | View |
| 2024-01-10 Tax Withholding | 2024-01-11 4:10 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 3,470 | $3 | 222,792 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:08 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | KLOSK STEVEN M Director | 19,480 | $0 | 49,570 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:06 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 19,480 | $0 | 39,480 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:05 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Flowers Cynthia Louise Director | 19,480 | $0 | 49,201 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:04 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | BROWN GREGORY B Director | 19,480 | $0 | 49,414 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 19,480 | $0 | 58,680 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-05 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 2,908 | $2.18 | 32,915 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:05 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 397 | $3.65 | 96,543 (Direct) | View |
| 2023-01-11 Tax Withholding | 2023-01-12 4:02 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 1,030 | $3.2 | 96,940 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:20 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Ruoslahti Erkki Director | 20,000 | $0 | 1,191,144 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:18 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | KLOSK STEVEN M Director | 20,000 | $0 | 30,090 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:17 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:15 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Flowers Cynthia Louise Director | 20,000 | $0 | 29,721 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:13 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | BROWN GREGORY B Director | 20,000 | $0 | 29,934 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:12 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 20,000 | $0 | 39,200 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:10 pm | 2023-01-09 2033-01-09 | LISATA THERAPEUTICS INC. | LSTA | Slack David W. President & CBO | 36,000 | $0 | 32,642 (Direct) | View |
| 2023-01-09 Tax Withholding | 2023-01-11 4:10 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Slack David W. President & CBO | 3,358 | $3 | 32,642 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:07 pm | 2023-01-09 2033-01-09 | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 90,000 | $0 | 127,970 (Direct) | View |
| 2023-01-09 Tax Withholding | 2023-01-11 4:07 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 7,845 | $3 | 127,970 (Direct) | View |
| 2023-01-10 Tax Withholding | 2023-01-11 4:07 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Mazzo David J Chief Executive Officer | 3,470 | $3.195 | 127,970 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:03 pm | 2023-01-09 2033-01-09 | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 27,000 | $0 | 44,823 (Direct) | View |
| 2023-01-09 Tax Withholding | 2023-01-11 4:03 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 2,147 | $3 | 44,823 (Direct) | View |
| 2023-01-10 Tax Withholding | 2023-01-11 4:03 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO | 512 | $3.195 | 44,823 (Direct) | View |
Ownership | 2022-09-16 4:51 pm | 2021-03-31 2029-12-03 | LISATA THERAPEUTICS INC. | LSTA | Slack David W. President & CBO | 0 | $0 | 254,889 (Direct) | View |
Ownership | 2022-09-16 4:50 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | Ruoslahti Erkki Director | 0 | $0 | 1,335,942 (Indirect) | View |
Ownership | 2022-09-16 4:48 pm | 2019-07-31 2029-04-08 | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 0 | $0 | 32,028 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-16 4:46 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | AZAB MOHAMMAD Director | 19,200 | $6.25 | 19,200 (Direct) | View |
| 2022-09-01 Tax Withholding | 2022-09-02 4:05 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 69,959 | $0.5 | 307,244 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:05 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 58,000 | $0.5 | 307,244 (Direct) | View |
| 2022-09-01 Tax Withholding | 2022-09-02 4:03 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 69,742 | $0.5 | 739,444 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:03 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 150,000 | $0.5 | 739,444 (Direct) | View |
| 2022-01-14 Tax Withholding | 2022-01-18 4:06 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 6,611 | $0.8204 | 631,065 (Direct) | View |
| 2022-01-13 Tax Withholding | 2022-01-18 4:06 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 6,471 | $0.8063 | 631,065 (Direct) | View |
| 2022-01-14 Tax Withholding | 2022-01-18 4:04 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Girolamo Todd C CLO, SVP of Corp Dev | 2,158 | $0.8204 | 160,827 (Direct) | View |
| 2022-01-13 Tax Withholding | 2022-01-18 4:04 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Girolamo Todd C CLO, SVP of Corp Dev | 2,563 | $0.8063 | 160,827 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:21 pm | 2022-01-10 2032-01-10 | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 601,000 | $0 | 844,147 (Direct) | View |
| 2022-01-11 Tax Withholding | 2022-01-12 4:21 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 16,740 | $0.8651 | 844,147 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 4:21 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Mazzo David J Chief Executive Officer | 56,410 | $0.917 | 844,147 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:20 pm | 2022-01-10 2032-01-10 | CALADRIUS BIOSCIENCES INC. | CLBS | Girolamo Todd C CLO, SVP of Corp Dev | 194,000 | $0 | 230,548 (Direct) | View |
| 2022-01-11 Tax Withholding | 2022-01-12 4:20 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Girolamo Todd C CLO, SVP of Corp Dev | 4,722 | $0.8651 | 230,548 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 4:20 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Girolamo Todd C CLO, SVP of Corp Dev | 17,405 | $0.917 | 230,548 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:18 pm | 2022-01-10 2032-01-10 | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 97,000 | $0 | 351,703 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 4:18 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO | 7,694 | $0.917 | 351,703 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:17 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Whitaker Anne Clem Director | 65,430 | $0 | 182,635 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:15 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | TRABER PETER G Director | 65,430 | $0 | 149,190 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:13 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | MYERS STEVEN S Director | 65,430 | $0 | 223,459 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:12 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | KLOSK STEVEN M Director | 65,430 | $0 | 151,390 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:10 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Flowers Cynthia Louise Director | 65,430 | $0 | 145,847 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:09 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Davidson Michael H. Director | 65,430 | $0 | 209,753 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:06 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | BROWN GREGORY B Director | 65,430 | $0 | 149,040 (Direct) | View |